JT
Tamburini Bonnefoy, Jérôme
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| The E3 ubiquitin ligase MARCH5 promotes mitochondrial fusion and cell-cycle progression in acute myeloid leukemia | Blood advances |  | 2025 | 70 | 26 | ||
| Effectiveness of fractionated rituximab in preventing tumor lysis syndrome in aggressive B-cell lymphoma : Insights from real-life clinical practice | Cancer reports | | 2024 | 64 | 212 | ||
| Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturation | Leukemia | | 2024 | 32 | 9 | ||
| Targeting ferritinophagy impairs quiescent cancer stem cells in acute myeloid leukemia in vitro and in vivo models | Science translational medicine |  | 2024 | 176 | 0 | ||
| Selective haematological cancer eradication with preserved haematopoiesis | Nature | | 2024 | 138 | 54 | ||
| AMPK activation induces immunogenic cell death in AML | Blood advances | | 2023 | 65 | 14 | ||
| Very short insertions in the FLT3 gene are of therapeutic significance in acute myeloid leukemia | Blood advances | | 2023 | 159 | 78 | ||
| Mitochondrial fusion is a therapeutic vulnerability of acute myeloid leukemia | Leukemia | | 2023 | 72 | 22 | ||
| Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma | Cell death and disease | | 2023 | 322 | 84 | ||
| An in vivo CRISPR screening platform for prioritizing therapeutic targets in AML | Cancer discovery | | 2022 | 361 | 298 | ||
| RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemia | Leukemia | | 2022 | 134 | 52 | ||
| T cell receptor sequencing reveals reduced clonal breadth of T-cell responses against SARS-CoV-2 after natural infection and vaccination in allogeneic hematopoietic stem cell transplant recipients | Annals of oncology | | 2022 | 255 | 83 | ||
| AMP-Activated Protein Kinase Contributes to Apoptosis Induced by the Bcl-2 Inhibitor Venetoclax in Acute Myeloid Leukemia | Cancers | | 2021 | 203 | 73 | ||
| Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemia | Science advances | | 2015 | 207 | 175 | ||
| The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation | Blood | | 2010 | 216 | 352 |
